Inhibiting the inhibitors, PTP1B as a therapeutic target in myocardial infarction
Biological systems self-regulate through cycles of activation and inactivation, the balance of which is critical in permitting or suppressing signaling cascades and their downstream consequences. Kinase signaling pathways are regulated through phosphorylation (activation) and dephosphorylation (inac...
Main Author: | Fiedler, L |
---|---|
Format: | Journal article |
Published: |
Openventio Publishers
2018
|
Similar Items
-
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
by: Jordi Olloquequi, et al.
Published: (2022-11-01) -
Dithiocarbamates as potential PTP1B inhibitors for diabetes management
by: Tanvi A. Deshpande, et al.
Published: (2022-01-01) -
Dual PTP1B/TC-PTP Inhibitors: Biological Evaluation of 3-(Hydroxymethyl)cinnoline-4(<i>1H</i>)-Ones
by: Kira V. Derkach, et al.
Published: (2023-02-01) -
Synthesis and Biological Evaluation of Analogues of Butyrolactone I as PTP1B Inhibitors
by: Bihong Hong, et al.
Published: (2020-10-01) -
Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives
by: Rongxing Liu, et al.
Published: (2022-06-01)